TWINGEN – protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer’s disease

INTRODUCTION: A better understanding of the earliest stages of Alzheimer’s disease (AD) could expedite the development or administration of treatments. Large population biobanks hold the promise to identify individuals at an elevated risk of AD and related dementias based on health registry informat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuoksimaa, Eero, Saari, Toni T., Aaltonen, Aino, Aaltonen, Sari, Herukka, Sanna-Kaisa, Iso-Markku, Paula, Kokkola, Tarja, Kyttälä, Aija, Kärkkäinen, Sari, Liedes, Hilkka, Ollikainen, Miina, Palviainen, Teemu, Ruotsalainen, Ilona, Toivola, Auli, Urjansson, Mia, Vasankari, Tommi, Vähä-Ypyä, Henri, Forsberg, Markus M., Hiltunen, Mikko, Jalanko, Anu, Kälviäinen, Reetta, Kuopio, Teijo, Lähteenmäki, Jaakko, Nyberg, Pia, Männikkö, Minna, Serpi, Raisa, Siltanen, Sanna, Palotie, Aarno, Kaprio, Jaakko, Runz, Heiko, Julkunen, Valtteri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635260/
https://www.ncbi.nlm.nih.gov/pubmed/37965200
http://dx.doi.org/10.1101/2023.11.03.23298018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635260/
https://www.ncbi.nlm.nih.gov/pubmed/37965200
http://dx.doi.org/10.1101/2023.11.03.23298018

Ejemplares similares